Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

Share Price is delayed by 15 minutes
Get Live Data
365.10    -2.30 (-0.63%)
Bid:
366.50
Ask:
366.80
Spread: 0.30 (0.082%)
Market Cap: £7.50b
MKS Live PriceLast checked at - London Stock Exchange

Intraday Marks & Spencer Share Chart

Directorate Change

17 Nov 2014 16:20

RNS Number : 2499X
Marks & Spencer Group PLC
17 November 2014
 



Issued: 17 November 2014

 

 

Marks and Spencer Group plc appoints Chief Finance Officer

 

 

Marks and Spencer Group plc (M&S) announces the appointment of Helen Weir to its Board as Chief Finance Officer. She will take up her appointment on a date to be confirmed.

 

Helen is currently Chief Financial Officer at the John Lewis Partnership. She joined John Lewis in 2012 from Lloyds Banking Group plc where she was Group Executive Director, Retail having been Group Finance Director at Lloyds from 2004-2008. Prior to this, Helen was Group Finance Director of Kingfisher plc, and Finance Director of B&Q. She spent her early career at Unilever and McKinsey & Co.

 

 

Marc Bolland, Chief Executive, M&S, said:

"We are delighted to be appointing Helen as CFO. She is extremely well qualified, and brings a wealth of relevant financial, retail and consumer experience. We look forward to her joining the M&S team."

 

 

Helen Weir said:

"M&S is one of the UK's great brands. This is an exciting time to be joining the company and I am delighted to be part of the team."

 

For further information, please contact:

Corporate Press Office 020 87181919

Investor Relations 020 8718 1563

 

 

Notes to Editors:

 

Helen is a Non-Executive Director of SAB Miller.

 

Previous non-executive appointments include City of London Investment Trust Plc, Royal Mail Holdings, Supervisory Board of Hornbach Holding AG and member of the Accounting Standards Board. 

 

Helen is a Fellow of the Chartered Institute of Management Accountants and was awarded a CBE for services to Finance in 2008.

 

Remuneration:

 

On appointment Helen will receive a basic annual salary of £590,000 and standard benefits commensurate with her position and in line with the M&S Remuneration Policy approved by shareholders in July 2014.

 

No share awards are being granted in relation to her appointment, however, Helen will receive a one-off payment of £188,500 to compensate for the differential in contractual pension that she is forfeiting to join M&S.

 

A further award for 2014/15 annual bonus foregone may also be taken into consideration.

 

 

- Ends -

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAMMMMMVNLGDZM
Date   Source Headline
1st Jun 202610:00 amRNSAnnual Financial Report
1st Jun 20269:00 amRNSIssue of Shares and Total Voting Rights
28th May 20264:23 pmRNSLichfield Fulfilment Centre Disposal Completion
28th May 20262:12 pmRNSDirector/PDMR Shareholding
22nd May 20262:00 pmRNSDirector/PDMR Shareholding
20th May 202610:30 amRNSDirectorate change
20th May 20267:00 amRNSFinal Results
1st May 20269:00 amRNSIssue of Shares and Total Voting Rights
28th Apr 20262:57 pmRNSDirector/PDMR Shareholding
28th Apr 202610:40 amRNSHolding(s) in Company
1st Apr 20269:00 amRNSIssue of Shares and Total Voting Rights
30th Mar 20262:07 pmRNSDirector/PDMR Shareholding
24th Mar 202610:35 amRNSDirector/PDMR Shareholding
2nd Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20261:00 pmRNSIssue of Shares and Total Voting Rights
19th Feb 20269:38 amRNSHolding(s) in Company
17th Feb 20263:23 pmRNSDirector/PDMR Shareholding
5th Feb 202611:48 amRNSDirector Declaration
3rd Feb 20269:57 amRNSDirector/PDMR Shareholding
2nd Feb 20269:00 amRNSTotal Voting Rights
29th Jan 202610:18 amRNSHolding(s) in Company
28th Jan 202610:42 amRNSDirector/PDMR Shareholding
12th Jan 20264:38 pmRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSChristmas Trading Results
2nd Jan 20269:00 amRNSTotal Voting Rights
2nd Jan 20269:00 amRNSBlock listing Interim Review
30th Dec 202512:40 pmRNSDirector/PDMR Shareholding
30th Dec 202512:40 pmRNSDirector/PDMR Shareholding
11th Dec 202510:00 amRNS2025 PSP Award Targets
10th Dec 202510:39 amRNSDirector/PDMR Shareholding
3rd Dec 20254:19 pmRNSDirector/PDMR Shareholding
3rd Dec 20251:43 pmRNSDirector/PDMR Shareholding
1st Dec 20255:34 pmRNSDirector/PDMR Shareholding
1st Dec 20259:00 amRNSTotal Voting Rights
28th Nov 202512:55 pmRNSDirector/PDMR Shareholding
17th Nov 20259:00 amRNSDirectorate change
12th Nov 20255:11 pmRNSDirector/PDMR Shareholding
12th Nov 20259:00 amRNSDirectorate change
11th Nov 202512:00 pmRNSInvestor Presentation
5th Nov 20257:00 amRNSHalf-year Financial Report
3rd Nov 20259:00 amRNSTotal Voting Rights
30th Oct 202510:00 amRNSDirectorate Change
28th Oct 20254:56 pmRNSDirector/PDMR Shareholding
14th Oct 202510:00 amRNSMarks and Spencer Chairmanship
1st Oct 20259:00 amRNSTotal Voting Rights
30th Sep 202511:36 amRNSDirector/PDMR Shareholding
1st Sep 20259:00 amRNSTotal Voting Rights
28th Aug 20252:23 pmRNSDirector/PDMR Shareholding
20th Aug 20259:30 amRNSDirectorate Change
1st Aug 20259:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.